Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...

Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...

Dr Debra Marcos offers expert insight on why GLP-1 medications like Wegovy and Mounjaro are not only transforming the weight ...

A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight, potentially transforming diabetes and obesity treatment.

While clearing up some misconceptions about her health journey, the actress, 44, reflected on the use of medicines like GLP-1 ...

More than a million Britons are now injecting themselves weekly with drugs-bought online or through private clinics-lured by ...

A guideline has recommended two key drugs be prescribed in all patients with type 2 diabetes who are at higher risk.